Early access to medicines scheme (EAMS) scientific opinion: Avelumab in the treatment of bladder cancer

Opinion issued for avelumab in treatment of adults with disease that has spread beyond the bladder (advanced urothelial carcinoma) and did not worsen after chemotherapy, comprising public assessment report, treatment protocols & background information for NHS Medical Directors.


Medicines and Healthcare products Regulatory Agency